Finally, we checked the effect of the compounds on cellular senescence in GNS166 and U87 cells, measured by Senescence-Associated Beta Galactosidase-positive cells, and found that both FRBs increased cell senescence in glioma cells at a higher rate than Tubastatin A (Figure 3H,I). The gene discussed is GLB1; the disease is glioma.